Mixed warm and cold autoimmune hemolytic anemia: Complete recovery after 2 courses of rituximab treatment [2]

Blood

Volumn 99, Issue 9, 2002, Pages 3478-3479

  Morselli, Monica ^a   Luppi, Mario ^a   Potenza, Leonardo ^a   Facchini, Luca ^a   Tonelli, Stefania ^a   Dini, Daniele ^a   Leonardi, Giovanna ^a   Donelli, Amedea ^a   Narni, Franco ^a   Torelli, Giuseppe ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; COLD AGGLUTININ; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PREDNISONE; RITUXIMAB;

AGED; AUTOIMMUNE HEMOLYTIC ANEMIA; CASE REPORT; DISEASE COURSE; DYSPNEA; FEMALE; HUMAN; LETTER; MUSCLE WEAKNESS; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0036565876     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-01-0018     Document Type: Letter

References (12)

1. Autoimmune hemolysis: An 18-year study of 865 cases referred to a regional transfusion centre
2. Autoimmune hemolytic anemia with both cold and warm autoantibodies
3. The polyneuropathy associated with Waldenström's macroglobulinaemia can be treated effectively with chemotherapy and the anti-CD20 monoclonal antibody rituximab
4. Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and hemolytic anemia
5. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura
6. Rituxan in the treatment of cold agglutinin disease
7. Remission of severe cold agglutinin disease after Rituximab therapy
8. Rituximab: A very efficient therapy in cold agglutinins and refractory autoimmune haemolytic anemia associated with CD-20 positive, low-grade non-Hodgkin lymphoma
9. Favourable response to therapy with the anti-CD20 monoclonal antibody rituximab in primary chronic cold agglutinin disease
10. Rituximab in a case of cold agglutinin disease
11. Effective treatment with rituximab in a patient with prolymphocytoid transformation of B chronic lymphocytic leukaemia and Evans syndrome
12. Treatment of refractory autoimmune haemolytic anaemia with anti-CD20 (Rituximab)